during the course of clinical studies to develop a new bivalent measles-mumps vaccine , it was established that simultaneous administration of live measles and mumps vaccines at doses contained in the monovalent vaccines resulted in a reduced seroconversion rate against mumps but not against measles .
C0026782
mumps vaccines
C0026780
mumps